Loading clinical trials...
Loading clinical trials...
Early MRSA Therapy in CF - Culture Based vs. Observant Therapy (Treat or Observe) (Star-TOO - STaph Aureus Resistance - Treat or Observe)
Conditions
Interventions
Rifampin
Trimethoprim/Sulfamethoxazole
+5 more
Locations
13
United States
The Children's Hospital-University of Birmingham
Birmingham, Alabama, United States
The Children's Hospital
Aurora, Colorado, United States
University of Florida
Gainesville, Florida, United States
University of Michigan Health System
Ann Arbor, Michigan, United States
Children's Hospitals and Clinics of Minnesota Minneapolis
Minneapolis, Minnesota, United States
St. Louis Children's Hospital
St Louis, Missouri, United States
Start Date
April 1, 2011
Primary Completion Date
January 1, 2015
Completion Date
May 1, 2015
Last Updated
May 15, 2017
NCT04469439
NCT04530383
NCT06154447
NCT05422222
NCT06984679
NCT02417740
Lead Sponsor
University of North Carolina, Chapel Hill
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions